Acute treatment of migraine w/ or w/o aura in adults. Preventive treatment of episodic migraine in adults who have at least 4 migraine attacks per mth.
Hypersensitivity reactions, including dyspnea & rash; discontinue if it occurs. Avoid the next dose w/in 48 hr when concomitantly administered w/ moderate CYP3A4 inhibitors. Not recommended for concomitant use w/ strong inhibitors & strong or moderate inducers of CYP3A4. Medication overuse headache. Not recommended in patients w/ severe hepatic impairment; ESRD (CrCl <15 mL/min). Severe renal impairment. Patients on dialysis. Avoid during pregnancy & lactation. Childn <18 yr.
Sign Out
